# OnCo record nct07063745 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07063745/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07063745", "NCT07063745" ;
  schema:name "A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion"@en ;
  schema:alternateName "MountainTAP-29"@en ;
  schema:description "A phase 2/3 trial testing Navlimetostat in non-small-cell lung cancer, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07063745/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07063745> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2/3" ;
  schema:startDate "2026-01-02" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:drugs <https://onco.cc/drugs/navlimetostat/> ;
  onco:companies <https://onco.cc/companies/bms/> .